News | May 25, 2022
IPCA Laboratories posts Rs. 130.23 crores consolidated profit in Q4FY22
The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.
The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of its continued focus on providing bioavailability enhancement series for global customers
Belmore, the brand name of Bempedoic acid, is a novel drug for the treatment of high LDL-cholesterol.
'Hello Skin' has been developed in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists)
Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease that can lead to substantial burden and often disability among patients
The technology was able to identify approximately 32 percent more adenomas than standard colonoscopy procedures
Approval follows CHMP recommendation for use in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19 vaccine
Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear
Results from the DELIVER and DAPA-HF Phase III trials demonstrate Dapagliflozin’ efficacy in heart failure regardless of ejection fraction
Subscribe To Our Newsletter & Stay Updated
